Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-21

Clinical Trial Update: Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema.

View source ↗

Summary

A retrospective study evaluated the efficacy and safety of the dexamethasone intravitreal implant (Ozurdex) in patients with diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Association for Innovation and Biomedical Research on Light and Image | Conditions: Diabetic Macular Edema | Status: COMPLETED